Primary Manuscripts

 

A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007)

McGowan I, Hoesley C, Cranston RD, Andrew P, Janocko L, Dai JY, Carballo-Dieguez A, Ayudhya RK, Piper J, Hladik F, et al. A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007). PLoS One 2013;8(4):e60147. PMCID:PMC3616022

 

Other Key Manuscripts

 

Mucosal effects of tenofovir 1% gel

Hladik F, Burgener A, Ballweber L, Gottardo R, Vojtech L, Fourati S, Dai JY, Cameron MJ, Strobl J, Hughes SM, et al. Mucosal effects of tenofovir 1% gel. eLife 2015 Feb 3;4. PMCID: PMC4391502

 

Use of a novel technology to track adherence to product use in a microbicide trial of short duration (MTN-007)

Leu CS, Mabragaña M, Giguere R, Dolezal C, Carballo-Diéguez A, McGowan I. Use of a novel technology to track adherence to product use in a microbicide trial of short duration (MTN-007). AIDS Behav 2013 Nov;17(9):3101-7. PMCID: PMC4157755